184 related articles for article (PubMed ID: 34235639)
21. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
22. 3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.
Fiasella A; Nuzzi A; Summa M; Armirotti A; Tarozzo G; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ChemMedChem; 2014 Jul; 9(7):1602-14. PubMed ID: 24828120
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Potential of Fatty Acid Amide Hydrolase, Monoacylglycerol Lipase, and N-Acylethanolamine Acid Amidase Inhibitors.
Tuo W; Leleu-Chavain N; Spencer J; Sansook S; Millet R; Chavatte P
J Med Chem; 2017 Jan; 60(1):4-46. PubMed ID: 27766867
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
[TBL] [Abstract][Full Text] [Related]
25. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
[TBL] [Abstract][Full Text] [Related]
26. Anti-Inflammatory Effects by Pharmacological Inhibition or Knockdown of Fatty Acid Amide Hydrolase in BV2 Microglial Cells.
Tanaka M; Yagyu K; Sackett S; Zhang Y
Cells; 2019 May; 8(5):. PubMed ID: 31121907
[TBL] [Abstract][Full Text] [Related]
27. NAAA inhibitor F96 attenuates BBB disruption and secondary injury after traumatic brain injury (TBI).
Li Y; Zhou P; Hu T; Ren J; Xu Y; Qiu Y; Lu C; Li Y
Eur J Pharmacol; 2021 Dec; 912():174561. PubMed ID: 34655598
[TBL] [Abstract][Full Text] [Related]
28. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
Fotio Y; Ciccocioppo R; Piomelli D
Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
[TBL] [Abstract][Full Text] [Related]
29. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
[TBL] [Abstract][Full Text] [Related]
30. Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies.
Tsuboi K; Zhao LY; Okamoto Y; Araki N; Ueno M; Sakamoto H; Ueda N
Biochim Biophys Acta; 2007 May; 1771(5):623-32. PubMed ID: 17462942
[TBL] [Abstract][Full Text] [Related]
31. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
[TBL] [Abstract][Full Text] [Related]
32. A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
Ribeiro A; Pontis S; Mengatto L; Armirotti A; Chiurchiù V; Capurro V; Fiasella A; Nuzzi A; Romeo E; Moreno-Sanz G; Maccarrone M; Reggiani A; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
ACS Chem Biol; 2015 Aug; 10(8):1838-46. PubMed ID: 25874594
[TBL] [Abstract][Full Text] [Related]
33. [Identify nature N-acylethanolamide-hydrolyzing acid amide (NAAA) inhibitor: effect of angelicae pubescentis radix on anti-inflammation].
Sun W; Yang L; Qiu Y; Ren J; Huang R; Fu J
Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(22):3161-6. PubMed ID: 22375399
[TBL] [Abstract][Full Text] [Related]
34. An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis.
Bonezzi FT; Sasso O; Pontis S; Realini N; Romeo E; Ponzano S; Nuzzi A; Fiasella A; Bertozzi F; Piomelli D
J Pharmacol Exp Ther; 2016 Mar; 356(3):656-63. PubMed ID: 26769918
[TBL] [Abstract][Full Text] [Related]
35. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
[TBL] [Abstract][Full Text] [Related]
36. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
[TBL] [Abstract][Full Text] [Related]
37. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
[TBL] [Abstract][Full Text] [Related]
39. Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH).
Sałaga M; Mokrowiecka A; Zakrzewski PK; Cygankiewicz A; Leishman E; Sobczak M; Zatorski H; Małecka-Panas E; Kordek R; Storr M; Krajewska WM; Bradshaw HB; Fichna J
J Crohns Colitis; 2014 Sep; 8(9):998-1009. PubMed ID: 24530133
[TBL] [Abstract][Full Text] [Related]
40. Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent
Di Fruscia P; Carbone A; Bottegoni G; Berti F; Giacomina F; Ponzano S; Pagliuca C; Fiasella A; Pizzirani D; Ortega JA; Nuzzi A; Tarozzo G; Mengatto L; Giampà R; Penna I; Russo D; Romeo E; Summa M; Bertorelli R; Armirotti A; Bertozzi SM; Reggiani A; Bandiera T; Bertozzi F
J Med Chem; 2021 Sep; 64(18):13327-13355. PubMed ID: 34469137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]